Literature DB >> 21300449

IMRT for image-guided single vocal cord irradiation.

Sarah O S Osman1, Eleftheria Astreinidou, Hans C J de Boer, Fatma Keskin-Cambay, Sebastiaan Breedveld, Peter Voet, Abrahim Al-Mamgani, Ben J M Heijmen, Peter C Levendag.   

Abstract

PURPOSE: We have been developing an image-guided single vocal cord irradiation technique to treat patients with stage T1a glottic carcinoma. In the present study, we compared the dose coverage to the affected vocal cord and the dose delivered to the organs at risk using conventional, intensity-modulated radiotherapy (IMRT) coplanar, and IMRT non-coplanar techniques. METHODS AND MATERIALS: For 10 patients, conventional treatment plans using two laterally opposed wedged 6-MV photon beams were calculated in XiO (Elekta-CMS treatment planning system). An in-house IMRT/beam angle optimization algorithm was used to obtain the coplanar and non-coplanar optimized beam angles. Using these angles, the IMRT plans were generated in Monaco (IMRT treatment planning system, Elekta-CMS) with the implemented Monte Carlo dose calculation algorithm. The organs at risk included the contralateral vocal cord, arytenoids, swallowing muscles, carotid arteries, and spinal cord. The prescription dose was 66 Gy in 33 fractions.
RESULTS: For the conventional plans and coplanar and non-coplanar IMRT plans, the population-averaged mean dose ± standard deviation to the planning target volume was 67 ± 1 Gy. The contralateral vocal cord dose was reduced from 66 ± 1 Gy in the conventional plans to 39 ± 8 Gy and 36 ± 6 Gy in the coplanar and non-coplanar IMRT plans, respectively. IMRT consistently reduced the doses to the other organs at risk.
CONCLUSIONS: Single vocal cord irradiation with IMRT resulted in good target coverage and provided significant sparing of the critical structures. This has the potential to improve the quality-of-life outcomes after RT and maintain the same local control rates.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300449     DOI: 10.1016/j.ijrobp.2010.12.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy.

Authors:  Abrahim Al-Mamgani; Peter H van Rooij; Robert Mehilal; Gerda M Verduijn; Lisa Tans; Stefan L S Kwa
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-25       Impact factor: 2.503

2.  Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Authors:  Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Parag Sevak; Jessica S Malek; Aasheesh Kanwar; Theodora Browne; G Brandon Gunn; Adam S Garden; Steven J Frank; William H Morrison; Jack Phan; Mark Zafereo; Heath Skinner; Stephen Y Lai; Katherine A Hutcheson; Jan S Lewin; Amy E Hessel; Apurva A Thekdi; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Laryngoscope       Date:  2019-02-12       Impact factor: 3.325

3.  Comparison of Voice Quality and Cost Effectiveness of Endoscopic Cordectomy Using Microdissection Electrodes with Laser Cordectomy and Radiotherapy.

Authors:  Mehmet Sürmeli; Cağatay Oysu; Ayşe Aslı Şahin Yılmaz; İldem Deveci; Burak Karabulut; Ahmet Volkan Sunter; Özgür Yiğit; Beyhan Ceylaner Bıcakçı
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-03-01

4.  Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-14

Review 5.  Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.

Authors:  D M Gujral; M Long; J W G Roe; K J Harrington; C M Nutting
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-11-01       Impact factor: 4.126

6.  Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Authors:  Stefan Janssen; Christoph Glanzmann; Gerhard Huber; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-06-13       Impact factor: 3.481

7.  Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer.

Authors:  Young Suk Kim; Jaegi Lee; Jong In Park; Wonmo Sung; Sol Min Lee; Gwi Eon Kim
Journal:  Radiat Oncol J       Date:  2016-03-30

8.  Carotid sparing intensity modulated radiotherapy on early glottic cancer: preliminary study.

Authors:  Hoon Sik Choi; Bae Kwon Jeong; Hojin Jeong; Jin Ho Song; Jin Pyeong Kim; Jung Je Park; Seung Hoon Woo; Ki Mun Kang
Journal:  Radiat Oncol J       Date:  2016-03-30

9.  Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.

Authors:  Yu Jin Lim; Hong-Gyun Wu; Tack-Kyun Kwon; J Hun Hah; Myung-Whun Sung; Kwang Hyun Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

10.  Consequences of tumor planning target volume reduction in treatment of T2-T4 laryngeal cancer.

Authors:  Cornelia A J M Vugts; Chris H J Terhaard; Marielle E P Philippens; Frank A Pameijer; Nicolien Kasperts; Cornelis P J Raaijmakers
Journal:  Radiat Oncol       Date:  2014-09-04       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.